Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 8/2019

01-08-2019 | Interventional Radiology

Microwave ablation assisted by three-dimensional visualization system as local therapy for relapsed hepatoblastoma: a small pilot study

Authors: Rui Cui, Jie Yu, Ying Gu, Feng Cao, Feng-Yong Liu, Li-Nan Dong, Ping Liang

Published in: Abdominal Radiology | Issue 8/2019

Login to get access

Abstract

Purpose

We aimed to explore the feasibility of microwave ablation (MWA) assisted by three-dimensional visualization system for relapsed HB in children.

Methods

From August 2014 to February 2017, five patients with relapsed HB were enrolled. A total of 12 liver tumors were treated with MWA assisted by a three-dimensional visualization system. Follow-up data were obtained in all patients. The residual liver volume, local tumor progression, new intrahepatic tumors, survival outcome, and complications were analyzed.

Results

All tumors were completely ablated in a single session. The mean ablation time per tumor was 9.7 ± 8.6 min, and the median ablation/liver volume ratio was 2.37%. No local tumor progression was observed during a follow-up period of 9–39 months. All patients were still alive at the end of the follow-up. The median progression-free survival time after ablation was 9 months, and the median survival time after ablation was 12 months. No other complications were observed except for fever.

Conclusions

MWA assisted by three-dimensional visualization system appears to be a safe and feasible local treatment for recurrent HB in pediatric patients.
Literature
1.
Piotr Czauderna, Dolores Lopez-Terrada, Eiso Hiyama et al (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr opin Pediatr 26(1):19-28.CrossRefPubMed
2.
3.
Matsunaga T, Sasaki F, Ohira M et al (2003) Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int 19:142-146.PubMed
4.
Malogolowkin MH, Katzenstein HM, Krailo M et al (2008) Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J Clin Oncol 26:2379-2383.CrossRefPubMedPubMedCentral
5.
Semeraro M, Branchereau S, Maibach R et al (2013) Relapses in hepatoblastoma patients: Clinical characteristics and outcome –Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). European Journal of Cancer 49:915-922.CrossRefPubMed
6.
Rajkumar Venkatramani, Wayne L. Furman, Joerg Fuchs et al (2012) Current and future management strategies for relapsed or progressive hepatoblastoma. Pediatric Drugs 14:221-232.CrossRefPubMed
7.
Otte JB, de Ville de Goyet J (2005) The contribution of transplantation to the treatment of liver tumors in children. Semin Pediatr Surg 14:233-238.CrossRefPubMed
8.
Rebecka L. Meyers, Greg Tiao, Jean de Ville de Goyet et al (2014) Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr 26(1):29-36.CrossRefPubMed
9.
Browne M, Sher D, Grant D (2008) Survival after liver transplantation for hepatoblastoma: a 2-center experience. J Pediatr Surg 43:1973-1981.CrossRefPubMed
10.
11.
Liu FY, Liang P, Yu XL et al (2013) Three-dimensional visualization preoperative treatment planning system in microwave ablation for liver cancer: a preliminary clinical application. Int J Hyperthermia 29: 671-677.CrossRefPubMed
12.
Li X, Yu J, Liang P et al (2017) Combination therapy of three-dimensional(3D) visualization operative treatment planning system and US-guided percutaneous microwave ablation in larger renal cell carcinomas (D≥4 cm): preliminary results. Int J Hyperthermia 33: 271-277.CrossRefPubMed
13.
Roebuck DJ, Aronson D, Clapuyt P et al (2007) 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 37:123-132.CrossRefPubMed
14.
Liu F, Cheng Z, Han Z et al (2017) A three-dimensional visualization preoperative treatment planning system for microwave ablation in liver cancer: a simulated experimental study. Abdom Radiol (NY) 42(6):1788-1793.CrossRef
15.
Muneeb Ahmed (2014) Image-guided Tumor ablation: Standardization of Terminology and Reporting Criteria - A 10-Year Update. Radiology 273(1): 241-260.CrossRefPubMed
16.
Yu J, Yu XL, Han ZY et al (2017) Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut 66: 1172-1173.CrossRefPubMed
17.
Groeschl RT, Pilgrim CH, Hanna EM et al (2013) Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg 259:1195-1200.CrossRef
18.
Wang CP, Wang HM, Yang WW et al (2014) Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology 61:1579-1590.CrossRef
19.
Zheng JS, Zhang HH, Sun Y et al (2013) CT-guided radiofrequency ablation following high-dose chemotherapy of a liver-metastasizing pancreatoblastoma with tumor thrombus in the portal vein. Pediatr Radiol 43:1391-1395.CrossRefPubMed
20.
McDaniel JD, Kukreja K, Ristagno R L et al (2013) Radiofrequency ablation of a large hepatic adenoma in a child. J Pediatr Surg 48:E19-22.CrossRefPubMed
21.
Ye JJ, Shu Q, Li MJ et al (2008) Percutaneous radiofrequency ablation for treatment of hepatoblastoma recurrence. Pediatr Radiol 38:1021-1023.CrossRefPubMed
22.
Van Laarhoven S, van Baren R, Tamminga RY et al (2012) Radiofrequency ablation in the treatment of liver tumors in children. Journal of Pediatric Surgery 47: E7-E12.CrossRefPubMed
23.
Rocourt DV, Shiels WE, Hammond S et al (2006) Contemporary management of benign hepatic adenoma using percutaneous radiofrequency ablation. J Pediatr Surg 41:1149-1152.CrossRefPubMed
24.
Zhou WB, Wang RX, Liu XA et al (2016) Ultrasound-guided microwave ablation: a promising tool in management of benign breast tumors. Int J Hyperthermia 11:1-8.
25.
Heck Kristina, Happel Christian, Grünwald Frank, Korkusuz Huedayi (2015) Percutaneous microwave ablation of thyroid nodules: effects on thyroid function and antibodies. Int J Hyperthermia 31: 560-567.CrossRef
26.
Ren C, Liang P, Yu XL et al (2016) Percutaneous microwave ablation of adrenal tumours under ultrasound guidance in 33 patients with 35 tumours: A single-centre experience. Int J Hyperthermia 32:517-523.CrossRefPubMed
27.
Wright AS, Lee FT, Mahvi DM (2003) Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 10:275-283.CrossRefPubMed
28.
Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14:199-208.CrossRefPubMed
29.
Liu BX, Zhou LY, Huang GL et al (2015) First Experience of ultrasound guided percutaneous ablation for recurrent hepatoblastoma after liver resection in children. Sci Rep 18(5):16805.CrossRef
30.
Naïk VV, Rafael D, Boris G et al (2018) Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomized controlled phase 2 trial. Lancet Gastroenterol Hepatol 3:317-325.CrossRef
31.
Kinoshita Y, Souzaki R, Tajiri T et al (2009) A preoperative evaluation for neo-infantile liver tumors using a three-dimensional reconstruction of multidetector row CT. Oncol Rep 21:881-886.CrossRefPubMed
32.
Schindl MJ, Redhead DN, Fearon KC et al (2005) The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54:289-296.CrossRefPubMedPubMedCentral
33.
Huo JH, Aloia TA, Xu Y et al (2019) Comparative Effectiveness of Computed Tomography Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma. Value Health 22:284-292.CrossRefPubMed
Metadata
Title
Microwave ablation assisted by three-dimensional visualization system as local therapy for relapsed hepatoblastoma: a small pilot study
Authors
Rui Cui
Jie Yu
Ying Gu
Feng Cao
Feng-Yong Liu
Li-Nan Dong
Ping Liang
Publication date
01-08-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02011-5

Other articles of this Issue 8/2019

Abdominal Radiology 8/2019 Go to the issue

Pelvis

Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancer

Letter to the Editor

Utility of magnetic resonance imaging for placenta accreta spectrum (PAS) disorders

Classics in Abdominal Radiology

The “inverted Napoleon’s hat” sign

Hepatobiliary

Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers

Kidneys, Ureters, Bladder, Retroperitoneum

Clinical significance of incidentally discovered renal cysts in pediatric patients

Classics in Abdominal Radiology

The “paper-thin wall” appearance in acute mesenteric ischemia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits